Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model

This publication has 14 references indexed in Scilit:

• Incorporation of an Active Site Inhibitor in Factor VIIa Alters the Affinity for Tissue Factor
  Published by Elsevier ,1997
• Prevention of experimental arterial thrombosis by topical administration of active site–inactivated factor VIIa
  Journal of Vascular Surgery, 1997
• Pharmacokinetics and delayed experimental antithrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor
  Thrombosis Research, 1996
• Cell biology of tissue factor, the principal initiator of blood coagulation
  Thrombosis Research, 1996
• Influence of Blockade at Specific Levels of the Coagulation Cascade on Restenosis in a Rabbit Atherosclerotic Femoral Artery Injury Model
  Circulation, 1995
• Active Site–Blocked Factors VIIa and IXa Differentially Inhibit Fibrin Formation in a Human Ex Vivo Thrombosis Model
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Regulation of the extrinsic pathway system in health and disease: The role of factor VIIa and tissue factor pathway inhibitor
  Thrombosis Research, 1995
• Relative roles of tissue factor pathway inhibitor and antithrombin in the control of thrombogenesis
  Blood Coagulation & Fibrinolysis, 1995
• The Tissue Factor Pathway: How It Has Become a “Prima Ballerina”
  Thrombosis and Haemostasis, 1995
• Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial.
  Circulation, 1994